Literature DB >> 1664256

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.

F P Guengerich1, D H Kim, M Iwasaki.   

Abstract

The role of human cytochrome P-450 IIE1 (P-450 IIE1) in the oxidation of a number of suspect carcinogens was examined by using a variety of approaches, including (1) selective inhibition of catalytic activity in human liver microsomes by diethyldithiocarbamate, which was found to be a selective mechanism-based inactivator of P-450 IIE1, (2) correlation of rates of different catalytic activities with each other and with chlorzoxazone 6-hydroxylation, an indicator of P-450 IIE1, in human liver microsomes, (3) demonstration of catalytic activity in reconstituted systems containing purified human P-450 IIE1, and (4) immunoinhibition of catalytic activity in human liver microsomes with rabbit anti-human P-450 IIE1. The results collectively indicate that P-450 IIE1 is a major catalyst of the oxidation of benzene, styrene, CCl4, CHCl3, CH2Cl2, CH3Cl, CH3CCl3, 1,2-dichloropropane, ethylene dichloride, ethylene dibromide, vinyl chloride, vinyl bromide, acrylonitrile, vinyl carbamate, ethyl carbamate, and trichloroethylene. Levels of P-450 IIE1 can vary considerably among individual humans--the availability of chlorzoxazone as a noninvasive probe of human P-450 IIE1 and of disulfiram (oxidized diethyldithiocarbamate) as an inhibitor may facilitate discernment of the in vivo significance of human P-450 IIE1 as a factor in the bioactivation and detoxication of these cancer suspects. Further, many investigations with diethyldithiocarbamate, disulfiram, and ethanol in humans and experimental animals may be interpreted in light of mechanisms involving P-450 IIE1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664256     DOI: 10.1021/tx00020a008

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  195 in total

1.  Persistent Organochlorine Exposure and Pregnancy Loss: A Prospective Cohort Study.

Authors:  Anna Z Pollack; Germaine M Buck Louis; Courtney D Lynch; Paul J Kostyniak
Journal:  J Environ Prot (Irvine, Calif)       Date:  2011-08-01

2.  Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

Review 3.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance.

Authors:  Haihong Zong; Michal Armoni; Chava Harel; Eddy Karnieli; Jeffrey E Pessin
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-20       Impact factor: 4.310

Review 5.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

6.  CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Guo-Wu Zhou; Jia Hu; Qiang Li
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

7.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

8.  Molecular probes of the mechanism of cytochrome P450. Oxygen traps a substrate radical intermediate.

Authors:  Harriet L R Cooper; John T Groves
Journal:  Arch Biochem Biophys       Date:  2010-11-12       Impact factor: 4.013

9.  Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Authors:  Gotaro Masuda; Akira Tokunaga; Takashi Shirakawa; Akiyoshi Togashi; Teruo Kiyama; Shunji Kato; Norio Matsukura; Hideki Bou; Masanori Watanabe; Takashi Tajiri
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

10.  Escherichia coli, Saccharomyces cerevisiae, rat and human 3-methyladenine DNA glycosylases repair 1,N6-ethenoadenine when present in DNA.

Authors:  M Saparbaev; K Kleibl; J Laval
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.